December 2, 2022
PHC Corporation
This is to inform the following changes will take place at PHC Corporation (headquarters: Minato-ku, Tokyo) effective January 1, 2023. The official decision was made by the Board of Directors.
1. New Appointment of President Effective January 1, 2023
＜New Appointment＞
| Position/Title |
Name |
Remarks |
| President |
Nobuaki Nakamura |
Corporate Officer,
Co-head of Diagnostics & Life Sciences Domain
PHC Holdings Corporation
Director, Biomedical Division PHC Corporation |
2. Resignation of President on December 31, 2022
＜Resignation＞
| Position/Title |
Name |
Remarks |
| President |
Kyoji Morimoto |
Corporate Officer,
Engineering and Manufacturing
PHC Holdings Corporation |
3. Board Members at PHC Corporation Effective January 1, 2023
| Position/Title |
Name |
Remarks |
| President |
Nobuaki Nakamura |
Corporate Officer,
Co-head of Diagnostics & Life Sciences Domain
PHC Holdings Corporation
Director, Biomedical Division PHC Corporation |
| Executive Managing Director |
Yuji Maruhashi |
Executive Director of Administration
PHC Corporation |
| Director |
Osamu Takahashi |
In charge of Medical Policy & Public Affairs
PHC Corporation |
| Director |
Takayuki Otsuka |
Corporate Officer,
Co-head of Healthcare Solutions Domain
PHC Holdings Corporation
Director,
Medical Information Systems Division
PHC Corporation |
| Director |
Hiroyuki Tokunaga |
Director,
In Vitro Diagnostics Division
PHC Corporation |
| Director |
Shinichi Iwana |
Director,
Advanced Technology Development Center
PHC Corporation |
| Director(part-time) |
Ryuichi Hirashima |
Senior Executive Corporate Officer
PHC Holdings Corporation |
Audit and Supervisory
Board Member |
Koichi Ikeuchi |
Audit and Supervisory,
Board Member
PHC Holdings Corporation |
Media contact
Investor Relations & Corporate Communications Department
PHC Holdings Corporation
+81-3-6778-5311
Email: phc-pr@gg.phchd.com